|
1
|
Kaufman DS, Shipley WU and Feldman AS:
Bladder cancer. Lancet. 374:239–249. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stein JP, Lieskovsky G, Cote R, Groshen S,
Feng AC, Boyd S, Skinner E, Bochner B, Thangathurai D, Mikhail M,
et al: Radical cystectomy in the treatment of bladder cancer:
Long-term results in 1,054 patients. J Clin Oncol. 19:666–675.
2001.PubMed/NCBI
|
|
3
|
Herr HW: Superiority of ratio based lymph
node staging for bladder cancer. J Urol. 169:943–945. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sarvaiya PJ, Guo D, Ulasov I, Gabikian P
and Lesniak MS: Chemokines in tumor progression and metastasis.
Oncotarget. 4:2171–2185. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Comerford I, Harata-Lee Y, Bunting MD,
Gregor C, Kara EE and McColl SR: A myriad of functions and complex
regulation of the CCR7/CCL19/CCL21 chemokine axis in the adaptive
immune system. Cytokine Growth Factor Rev. 24:269–283. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cassier PA, Treilleux I, Bachelot T,
Ray-Coquard I, Bendriss-Vermare N, Ménétrier-Caux C, Trédan O,
Goddard-Léon S, Pin JJ, Mignotte H, et al: Prognostic value of the
expression of C-Chemokine receptor 6 and 7 and their ligands in
non-metastatic breast cancer. BMC Cancer. 11:2132011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cunningham HD, Shannon LA, Calloway PA,
Fassold BC, Dunwiddie I, Vielhauer G, Zhang M and Vines CM:
Expression of the C-C chemokine receptor 7 mediates metastasis of
breast cancer to the lymph nodes in mice. Transl Oncol. 3:354–361.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Baltaci S, Resorlu B, Yagci C, Turkolmez
K, Gogus C and Beduk Y: Computerized tomography for detecting
perivesical infiltration and lymph node metastasis in invasive
bladder carcinoma. Urol Int. 81:399–402. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li Z, Qi F, Miao J, Zu X, He W, Wang L and
Qi L: Vascular endothelial growth factor-C associated with computed
tomography used in the diagnosis of lymph node metastasis of
bladder carcinoma. Arch Med Res. 41:606–610. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Montironi R and Lopez-Beltran A: The 2004
WHO classification of bladder tumors: A summary and commentary. Int
J Surg Pathol. 13:143–153. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cheng L, Montironi R, Davidson DD and
Lopez-Beltran A: Staging and reporting of urothelial carcinoma of
the urinary bladder. Mod Pathol. 22:S70–95. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim H, Kim M, Kwak C, Kim HH and Ku JH:
Prognostic significance of lymphovascular invasion in radical
cystectomy on patients with bladder cancer: A systematic review and
meta-analysis. PLoS One. 9:e892592014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zaravinos A, Volanis D, Lambrou GI,
Delakas D and Spandidos DA: Role of the angiogenic components,
VEGFA, FGF2, OPN and RHOC, in urothelial cell carcinoma of the
urinary bladder. Oncol Rep. 28:1159–1166. 2012.PubMed/NCBI
|
|
15
|
Kamat AM, Vlahou A, Taylor JA, Hudson ML,
Pesch B, Ingersoll MA, Todenhöfer T, van Rhijn B, Kassouf W, Barton
Grossman H, et al: Considerations on the use of urine markers in
the management of patients with high-grade non-muscle-invasive
bladder cancer. Urol Oncol. 32:1069–1077. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Türkölmez K, Tokgöz H, Reşorlu B, Köse K
and Bedük Y: Muscle-invasive bladder cancer: Predictive factors and
prognostic difference between primary and progressive tumors.
Urology. 70:477–481. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kakinuma T and Hwang ST: Chemokines,
chemokine receptors, and cancer metastasis. J Leukoc Biol.
79:639–651. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Homey B, Müller A and Zlotnik A:
Chemokines: Agents for the immunotherapy of cancer? Nat Rev
Immunol. 2:175–184. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hao M, Zheng J, Hou K and Wang J, Chen X,
Lu X, Bo J, Xu C, Shen K and Wang J: Role of chemokine receptor
CXCR7 in bladder cancer progression. Biochem Pharmacol. 84:204–214.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zlotnik A, Burkhardt AM and Homey B:
Homeostatic chemokine receptors and organ-specific metastasis. Nat
Rev Immunol. 11:597–606. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yates TJ, Knapp J, Gosalbez M, Lokeshwar
SD, Gomez CS, Benitez A, Ekwenna OO, Young EE, Manoharan M and
Lokeshwar VB: C-X-C chemokine receptor 7: A functionally associated
molecular marker for bladder cancer. Cancer. 119:61–71. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Irino T, Takeuchi H, Matsuda S, Saikawa Y,
Kawakubo H, Wada N, Takahashi T, Nakamura R, Fukuda K, Omori T and
Kitagawa Y: CC-Chemokine receptor CCR7: A key molecule for lymph
node metastasis in esophageal squamous cell carcinoma. BMC Cancer.
14:2912014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee HJ, Song IC, Yun HJ, Jo DY and Kim S:
CXC chemokines and chemokine receptors in gastric cancer: From
basic findings towards therapeutic targeting. World J
Gastroenterol. 20:1681–1693. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Guo J, Lou W, Ji Y and Zhang S: Effect of
CCR7, CXCR4 and VEGF-C on the lymph node metastasis of human
pancreatic ductal adenocarcinoma. Oncol Lett. 5:1572–1578.
2013.PubMed/NCBI
|
|
25
|
Ficarra V, Dalpiaz O, Alrabi N, Novara G,
Galfano A and Artibani W: Correlation between clinical and
pathological staging in a series of radical cystectomies for
bladder carcinoma. BJU Int. 95:786–790. 2005. View Article : Google Scholar : PubMed/NCBI
|
